{"id":13560,"date":"2010-06-29T14:11:47","date_gmt":"2010-06-29T12:11:47","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=13560"},"modified":"2022-09-14T13:10:19","modified_gmt":"2022-09-14T11:10:19","slug":"cisneros-c-quiralte-j-capel-m-casado-ma-mellstrom-c","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/cisneros-c-quiralte-j-capel-m-casado-ma-mellstrom-c\/","title":{"rendered":"Cisneros C, Quiralte J, Capel M, Casado MA, Mellstrom C"},"content":{"rendered":"<div class=\"miniatura_foto\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-13467 alignleft\" src=\"https:\/\/porib.com\/wp-content\/uploads\/2020\/10\/pharmacoeconomics_spanish_research_articles.jpg\" alt=\"\" width=\"90\" height=\"120\" \/><\/div>\n<p><strong>Cisneros C, Quiralte J, Capel M, Casado MA, Mellstrom C<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h6 style=\"text-align: justify;\">An\u00e1lisis coste-efectividad de budenosida\/formoterol en el tratamiento de mantenimiento y a demanda (Symbicort SMART\u00ae) frente a salmeterol\/fluticasona m\u00e1s terbutalina, en el tratamiento del asma persistente en Espa\u00f1a<\/h6>\n<h6 style=\"text-align: justify;\"><strong>Pharmacoeconomics Span Res Art. 2010;7(4):163-75<\/strong><\/h6>\n<div class=\"col80p\">\n<p style=\"text-align: justify;\"><a href=\"http:\/\/link.springer.com\/article\/10.1007\/BF03321485\" target=\"_blank\" rel=\"noopener\">M\u00c1S INFORMACI\u00d3N<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Cisneros C, Quiralte J, Capel M, Casado MA, Mellstrom C &nbsp; &nbsp; An\u00e1lisis coste-efectividad de budenosida\/formoterol en el tratamiento de mantenimiento y a demanda (Symbicort SMART\u00ae) frente a salmeterol\/fluticasona m\u00e1s terbutalina, en el tratamiento del asma persistente en Espa\u00f1a Pharmacoeconomics Span Res Art. 2010;7(4):163-75 M\u00c1S INFORMACI\u00d3N<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"quote","meta":{"footnotes":""},"categories":[116,926,304],"tags":[],"class_list":["post-13560","post","type-post","status-publish","format-quote","hentry","category-ace-acu-tipo-de-proyecto","category-neumologia","category-pharmacoeconomics-spanish-research-articles","post_format-post-format-quote"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13560"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=13560"}],"version-history":[{"count":2,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13560\/revisions"}],"predecessor-version":[{"id":22421,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13560\/revisions\/22421"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=13560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=13560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=13560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}